 | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C17H23NO4 |
| Molar mass | 305.374 g·mol−1 |
| 3D model (JSmol) | |
| |
Cetraxate (INN) is an oralgastrointestinalmedication which has a cytoprotective effect.[1][2][unreliable medical source?]
Cetraxate is aprodrug oftranexamic acid. The latter is ahemostatic agent because it inhibits the activation ofplasminogen toplasmin. The result is to prevent excess loss of blood ingastrointestinal ulcers.The synthesis begins with theesterification of 3-(p-hydroxyphenyl)propionic acid (2) bytrans-4-cyanocyclohexanecarbonyl chloride (1). The product (3) is reduced tocetraxate (4) bycatalytic hydrogenation withhydrogen andRaney nickel.[3][4]
 | Thisdrug article relating to thegastrointestinal system is astub. You can help Wikipedia byexpanding it. |
